Gimv

Gimv is a European private equity firm that invests in selected investment platforms with a focus on Benelux, France, and Germany.

Business Model:

Revenue: $358.9M

Employees: 51-200

Rankings

Detailed Gimv Information

Geographic Data

Gimv headquarters map

Address: Karel Oomsstraat 37

City: Antwerp

State: antwerp

Zip: 2018

Country: BE

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

2,125,919Website Global Rank

9,140Website Monthly Traffic

Twitter Followers

Description

Gimv is a European investment company with over three decades of experience in private equity and venture capital. Gimv is listed on NYSE Euronext Brussels. Gimv currently manages around 1.8 billion EUR (including third party funds) of investments in 85 portfolio companies, which jointly realise a turnover of more than EUR 6 billion and employ over 28,000 professionals. As a recognized market leader in selected investment platforms, Gimv identifies entrepreneurial and innovative companies with high-growth potential and supports them in their transformation into market leaders. Gimv’s four investment platforms are: Consumer 2020, Health &a; Care, Smart Industries and Sustainable Cities. Each of these platforms works with a skilled and dedicated team across Gimv’s home markets of the Benelux, France and Germany and can count on an extended international network of experts. More information on Gimv can be found on [www.gimv.com].

Contact Phone:
+13232902100

Contact Email:

Gimv went public on 4/1/1999 on the EBR

Listed Exchange:
EBR

IPO Date:
4/1/1999

Ticker Symbol:
GIMB

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
9/2012 GOVECS Venture Round 12.6M
1/2017 Itineris Venture Round 11.1M
4/2009 Luma International Series A 3.9M
1/1999 Arrow Therapeutics Seed Round 1.7M
12/2007 Fovea Pharmaceuticals Series B 30M
1/2018 Stiplastics S.A.S. Venture Round -
10/2010 DataContact Venture Round 4.2M
4/2004 Interwise Series E -
2/2013 Multiplicom Venture Round 7.4M
4/2004 Ablynx Series B 30M
1/2016 Legallais Private Equity Round -
7/2021 Topas Therapeutics Series B 0
12/2006 Xanthus Pharmaceuticals Series B 0
1/2013 Biotalys Venture Round 0
8/2009 Ubidyne Series B 0
8/2007 Nereus Pharmaceuticals Series D 0
7/2006 CoreOptics Venture Round 0
11/2003 CoreOptics Series C 0
10/2003 Arrow Therapeutics Series B 34.9M
3/2017 Biotalys Series B 0
10/2013 NovoPolymers Private Equity Round -
1/2013 McPhy Venture Round 13.4M
4/2008 Openbravo Series B 12M
12/2019 General Fusion Series E 0
11/2018 Precirix Series A 41.9M
10/2006 Santhera Pharmaceuticals Series C 0
3/2000 Innate Pharma Series A 4.4M
9/2010 Inside Secure Series D 0
7/2007 Inside Secure Series B 0
6/2009 Pronota Series B 7.4M
10/2010 Nomadesk Series B 7M
9/2021 Anjarium Biosciences Series A 60.4M
8/2015 CoScale Venture Round 0
5/2004 Plexxikon Series B 0
7/2007 CoWare Series F 7M
4/2022 BioConnection Secondary Market -
4/2014 JenaValve Technology Series C 0
4/2010 Liquavista Series D 9.5M
12/2003 Xanthus Pharmaceuticals Series B 0
5/2005 Ambit Biosciences Series C 31M
3/2007 Nomadesk Series A 0
6/2016 Riaktr (formely Real Impact Analytics) Series A 13.5M
8/2002 CoWare Series D 8M
4/2023 Complement Therapeutics Series A 0
3/2023 Mediar Therapeutics Series A 0
2/2023 Paleo Series A 0
3/2005 TorreyPines Therapeutics Series C 0
10/2005 Nereus Pharmaceuticals Series D 0
7/2012 ARS Traffic &a; Transport Technology Private Equity Round -
4/2011 Multiplicom Venture Round 2.9M
1/2002 Innate Pharma Series B 17.8M
7/2013 JenaValve Technology Series C 62.5M
7/2003 Elixent Series B 10M
2/2020 JenaValve Technology Series D 0
6/2022 ImCheck Therapeutics Series C 0
6/2010 JenaValve Technology Series B 22.7M
10/2011 TrustTeam Private Equity Round -
8/2015 JenaValve Technology Series C 26.5M
11/2013 Endosense Series C 41.2M
10/2006 Accent Jobs for People Private Equity Round -
8/2006 ChemoCentryx Series C 0
9/2016 spineart Venture Round 33.5M
10/2009 GreenPeak Technologies Series B 0
9/2010 Private Outlet Venture Round 6.5M
2/2012 Oldelft Ultrasound Private Equity Round -
5/2004 Psytechnics Series C 11.6M
10/2000 Hypnion Series A 10.4M
3/2021 sofatutor Venture Round -
7/2021 Klotter Private Equity Round -
6/2013 Lampiris Venture Round 53.4M
7/2019 Biotalys Series C 0
4/2016 Onward Series A 29.5M
2/2009 ActoGeniX Private Equity Round 17.4M
2/2007 ActoGeniX Venture Round 26.1M
10/1999 Devgen Series B 24.7M
1/2012 Pronota Series C 4.8M
1/2007 Movetis Series A 63.8M
4/2000 Nereus Pharmaceuticals Series A 8.6M
8/2011 Studiekring Private Equity Round -
8/2006 Psytechnics Venture Round -
8/2012 Movea Venture Round 8M
7/2017 Arseus Medical Private Equity Round -
4/2008 CoreOptics Venture Round 0
7/2003 PamGene Series B 11.3M
3/2012 NovoPolymers Venture Round 7.1M
11/2015 Equipe Zorgbedrijven Private Equity Round 12.5M
12/2014 Well Services Group Private Equity Round 8.7M
3/2009 Vandemoortele Private Equity Round 99.8M
5/2006 GreenPeak Technologies Venture Round 11.1M
12/2006 Liquavista Series A 15.9M
9/2003 CoWare Series E 13M
3/2008 Liquavista Series B 12.6M
12/2013 Eurocept Private Equity Round -
8/2014 Ablynx Grant 2.8M
9/2002 Ablynx Series A 4.9M
12/2003 Proficient Systems Venture Round 5M
12/2002 Arrow Therapeutics Venture Round 10.9M
7/2010 McPhy Venture Round 17.1M
11/2005 Fovea Pharmaceuticals Series A 24.2M
9/2011 ActivePath Series B 10M
1/2008 VirtenSys Series B 12M
12/2013 Transdev Private Equity Round -
7/2000 Arrow Therapeutics Series A 16.6M
8/2006 Pronota Series A 10.6M
10/2006 VirtenSys Series A 12M
6/2018 Kind Technologies Venture Round -
11/2014 Melijoe Venture Round 11.2M
11/2012 Ambit Biosciences Venture Round 0
6/2006 Clear2Pay Series D 19.8M
3/2007 ChemoCentryx Series D 29.8M
6/2011 Ambit Biosciences Series D 0
11/2012 Endosense Series C 40.3M
10/2001 Interwise Series C 34M
5/2016 EndoStim Series D 25M
5/2015 Itineris Venture Round 10M
6/2013 Complix Series B 15.6M
9/2015 Biom&s;Up Series C 35.3M
11/2020 Kinaset Therapeutics Series A 40M
3/2012 GreenWatt Venture Round 0
2/2020 JenaValve Technology Venture Round 50M
4/2005 Elixent Series C 15M
3/2023 FIRE1 Venture Round 0
11/2003 Neurotech Venture Round 14.1M
5/2007 Oree Advanced Illumination Solutions Series A 7M
2/2011 NovoPolymers Series B 5.7M
3/2006 Gemidis Series C 8.1M
8/2011 Teads US Private Equity Round 25M
2/2005 Proficient Systems Series B 375k
5/2009 NovoPolymers Series A 4M
11/2001 ORMvision Series B 1.8M
12/2000 PamGene Series A 6.2M
5/2017 ImCheck Therapeutics Series A 21.9M
4/2016 Joolz Private Equity Round -
10/2009 Easyvoyage Private Equity Round 16.2M
11/2005 Inside Secure Series A 10.9M
9/2004 Innate Pharma Series C 0
1/2012 Prosensa Venture Round 0
12/2005 Santhera Pharmaceuticals Series B 0
12/2013 Covagen Series B 0
8/2004 AGY Therapeutics Series C 9M
8/2022 JenaValve Technology Series C 0
5/2012 Prosonix Series B 0
3/2016 Topas Therapeutics Series A 0
11/2007 Ambit Biosciences Series D 49.3M
9/2021 Paperspace Series F 0
11/2012 Jeeng Series A 10M
7/2002 Proficient Systems Series B 6M
10/2020 Topas Therapeutics Series B 0
12/2005 Hypnion Series B 0
6/1999 CoWare Series B 8M
6/2022 ImmunOs Therapeutics Series B 0
1/2008 Inside Secure Series C 0
12/2008 Clear2Pay Venture Round 8.3M
3/2022 Precirix Series B 0
3/2004 CareX SA Series B 32M
9/2011 Seedcamp Seed Round -
1/2018 FIRE1 Series C 49.6M
4/2021 Onward Venture Round 0
12/2019 ImCheck Therapeutics Series B 53.2M
3/2017 Breath Therapeutics Series A 45.9M
10/2009 Endosense Series B 0
1/2008 Movea Venture Round 10.7M
10/2016 MEGA International Private Equity Round -
9/2017 Cegeka Venture Round -
4/2010 RES Software Venture Round 6.2M
11/2013 Almaviva Santé Private Equity Round 54.4M
3/2008 Viabuild Private Equity Round -
7/2007 Diatos Series D 12.8M
5/2016 Arplas Systems Private Equity Round 11.4M
8/2011 XL Video Venture Round 27.1M
9/2019 iSTAR Medical Series C 44.1M
3/2003 Hypnion Series B 47.5M
9/2014 thinkstep Series B 10.5M
8/2006 Ablynx Series C 50M
3/2016 Contraload Private Equity Round -
3/2020 AME Private Equity Round -
6/2013 Marco Vasco Series A 20.1M
1/2015 Teads US Series B 30M
12/2008 Prosensa Series B 25.8M
6/2004 ChemoCentryx Series B 33M
8/2009 Micron Technology Series C 16M
4/2023 Complement Therapeutics Series A 0
3/2023 FIRE1 Venture Round 0
3/2023 Mediar Therapeutics Series A 0
2/2023 Paleo Series A 0
8/2022 JenaValve Technology Series C 0
6/2022 ImCheck Therapeutics Series C 0
6/2022 ImmunOs Therapeutics Series B 0
4/2022 BioConnection Secondary Market -
3/2022 Precirix Series B 0
9/2021 Paperspace Series F 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research
CoBee's Logo
Copyright © CoBee 2022. All Rights Reserved.